SHR-1905 Placebo Injection

DRUG3 trials

Sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd

Conditions

AsthmaChronic Rhinosinusitis With Nasal Polyps

Phase 2

Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

CompletedNCT05891483

Guangdong Hengrui Pharmaceutical Co., LtdChronic Rhinosinusitis With Nasal Polyps

Start: 2023-09-04End: 2026-01-21Updated: 2026-07-22

Phase 3

A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

RecruitingNCT07098403

Guangdong Hengrui Pharmaceutical Co., LtdAsthma

Start: 2025-09-03End: 2028-06-30Target: 408Updated: 2025-09-09

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

RecruitingNCT07132827

Guangdong Hengrui Pharmaceutical Co., LtdChronic Rhinosinusitis With Nasal Polyps

Start: 2025-08-28End: 2028-04-30Target: 280Updated: 2025-11-17